Eradivir (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 25, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $10,250,000
Company Info
- Founders
- Martin Low
- Company Description
- Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.
- Market
- Immunotherapy
- Location
- West Lafayette, IN, USA